Capvaxive Patient Assistance Program
Don’t let the high cost of brand 21-valent pneumococcal conjugate vaccine disrupt your adult immunization. We help eligible patients access Capvaxive (pneumococcal 21-valent conjugate vaccine) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Capvaxive (pneumococcal 21-valent conjugate vaccine) is FDA-approved (2024) for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults 18 years and older. Contains 21 pneumococcal serotypes specifically designed for adult disease epidemiology — covering ~84% of invasive pneumococcal disease in adults 65+ (differs from pediatric-derived Prevnar formulations).
- Without assistance, Capvaxive costs commonly run approximately $200–$250 per dose.
- Through AffordMyPrescriptions, qualifying patients can access Capvaxive for a flat $69.95 per month.
- Other pneumococcal vaccines: Prevnar 20 (PCV20 — brand; 20-valent conjugate), Vaxneuvance (PCV15 — 15-valent conjugate), Prevnar 13 (PCV13 — historical), Pneumovax 23 (PPSV23 — polysaccharide, historical adult vaccine). ACIP now recommends one dose of PCV20 or PCV21 (Capvaxive), or Vaxneuvance + Pneumovax 23, for adults 50 years and older (2024 update lowered from 65+). Under ACA, ACIP-recommended vaccines are covered without cost-sharing. IRA — Medicare Part D covers adult vaccines at $0 (2023).
What is Capvaxive Prescription Assistance Program?
The Capvaxive Patient Assistance Program helps eligible patients access this 21-valent pneumococcal vaccine at little or no cost when meeting income, insurance, and clinical criteria. Under ACA, most privately insured have vaccine coverage without cost-sharing.
At AffordMyPrescriptions, our Patient Advocates handle the entire Capvaxive PAP enrollment for a flat $69.95 per month — so you never face a gap in your pneumococcal immunization.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Capvaxive enrollment — so you never face a gap in your pneumococcal disease prevention.
Pharmacy Price Comparison
- Without assistance, Capvaxive costs hundreds per dose. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| ACA / Medicare $0 vaccine | $0 | ACA covered without cost-share |
| Walgreens | ~$240/dose | Save substantially |
| CVS Pharmacy | ~$250/dose | Save substantially |
| Walmart | ~$210/dose | Save substantially |
| Costco | ~$200/dose | Save substantially |
| Prevnar 20 (alt PCV20) | ~$240/dose | Alt broader-spectrum PCV |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Capvaxive — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Capvaxive Prescription Program?
The Capvaxive Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Under ACA and IRA Medicare Part D, ACIP-recommended vaccines are covered without cost-sharing — verify coverage. Multiple effective pneumococcal vaccines are available; ACIP recommendations updated in 2024 lowered the age from 65+ to 50+ for adult pneumococcal vaccination.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Capvaxive assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Capvaxive is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Capvaxive:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $200–$250/dose even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Capvaxive assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Capvaxive Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Capvaxive:
Capvaxive is a 21-valent pneumococcal conjugate vaccine specifically designed for adult disease epidemiology — covering pneumococcal serotypes most common in adult invasive pneumococcal disease. Approved in 2024. One-time dose per current ACIP guidance.
How It Works:
Streptococcus pneumoniae (pneumococcus) causes pneumonia, meningitis, sepsis, otitis media, and other infections. Adults 65+ and adults with certain medical conditions have the highest invasive pneumococcal disease risk. Historically PCV7 → PCV13 (Prevnar 13) → PCV15 (Vaxneuvance) → PCV20 (Prevnar 20) → PCV21 (Capvaxive) — expanding serotype coverage. Polysaccharide PPSV23 (Pneumovax 23) covered more serotypes but with less durable immunity than conjugate vaccines. Conjugate vaccines link pneumococcal capsular polysaccharides to a carrier protein — eliciting a durable T-cell-dependent immune response with memory. Capvaxive is engineered for adult disease epidemiology — covering 21 serotypes most common in adult invasive pneumococcal disease (~84% coverage in adults 65+). ACIP recommends one dose of PCV20 or PCV21 (Capvaxive), or PCV15+PPSV23, for adults 50 years and older per the 2024 update.
Form and Use:
Capvaxive 0.5 mL IM injection in the deltoid. One-time dose per ACIP recommendation for adults 50+. Given at pharmacy, clinic, or occupational health.
Generic Availability:
No generic Capvaxive. Other pneumococcal vaccines: Prevnar 20 (PCV20 — 20-valent conjugate, adult and pediatric — brand), Vaxneuvance (PCV15 — 15-valent conjugate — brand), Prevnar 13 (PCV13 — historical), Pneumovax 23 (PPSV23 — 23-valent polysaccharide, historical adult). ACIP 2024 recommendation: adults 50+ receive one dose of PCV20 or PCV21 (Capvaxive), OR Vaxneuvance (PCV15) followed by Pneumovax 23 (PPSV23). Adults with certain immunocompromising or high-risk conditions may need an additional dose. Under ACA and IRA Medicare Part D, ACIP-recommended vaccines are covered without cost-sharing. CDC and ACIP resources.
Warnings:
Anaphylaxis and severe allergic reactions (rare — do not administer to persons with severe allergic reaction to prior pneumococcal vaccine or component), thrombocytopenia (rare after conjugate vaccine), embryo-fetal considerations (generally safe in pregnancy), Guillain-Barré syndrome (temporal association possible with any vaccine). Other: injection site pain, redness, swelling; fatigue, headache, myalgia. Immunocompromised persons may have a reduced immune response.
FAQ (Frequently Asked Questions)
How much does Capvaxive cost without insurance?
$200–$250 per dose at pharmacies. Prevnar 20 (alternative PCV20) is similarly priced. Under ACA, ACIP-recommended vaccines are covered without cost-sharing for most privately insured. IRA — Medicare Part D covers adult vaccines at $0 (2023). Verify with insurance.
How is Capvaxive different from Prevnar 20 (PCV20)?
Both are conjugate pneumococcal vaccines for adults. Prevnar 20 is 20-valent, extending the PCV13 lineage with pediatric-derived serotypes. Capvaxive is 21-valent, specifically designed for adult disease epidemiology — covering serotypes most common in adult invasive pneumococcal disease (~84% coverage in adults 65+; a different serotype panel). Both are ACIP-recommended options.
Who should get Capvaxive?
Adults 50 years and older per ACIP 2024 update (lowered from 65+). Adults 19–49 with certain medical conditions (immunocompromise, chronic diseases, CSF leaks, cochlear implants) at higher risk. One dose of PCV20 or PCV21 (Capvaxive), or PCV15+PPSV23, is recommended for the ACIP-defined populations. Discuss with your primary care provider.
Do I need Pneumovax 23 also?
Depends on which vaccine you receive. If PCV20 (Prevnar 20) or PCV21 (Capvaxive) — one dose is typically sufficient for most adults. If Vaxneuvance (PCV15) — followed by Pneumovax 23 (PPSV23) usually 1+ year later. Adults previously vaccinated may need catch-up per ACIP. Discuss with your primary care provider.
What are Capvaxive side effects?
Injection site pain, redness, swelling (common); fatigue, headache, myalgia. Serious reactions rare — anaphylaxis (extremely rare), thrombocytopenia (rare with conjugate vaccines). Not contraindicated in immunocompromised persons but immune response may be reduced.
Take Control of Your Medication Costs
Adult pneumococcal vaccination prevents serious pneumonia and invasive disease. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.